NMR structural determinants of eosinophil cationic protein binding to membrane and heparin mimetics

Biophysical Journal

Volumn 98, Issue 11, 2010, Pages 2702-2711

  García Mayoral, María Flor ^a   Moussaoui, Mohammed ^b   De La Torre, Beatriz G ^c   Andreu, David ^c   Boix, Ester ^b   Nogués, M Victòria ^b   Rico, Manuel ^a   Laurents, Douglas V ^a   Bruix, Marta ^a  

^a INSTITUTO DE QUÍMICA FÍSICA ROCASOLANO   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77953007365     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2010.02.039     Document Type: Article

References (58)

1. Mohan, C. G., E. Boix, ...,K. R. Acharya. 2002. The crystal structure of eosinophil cationic protein in complex with 2′,5′-ADP at 2.0 A resolution reveals the details of the ribonucleolytic active site. Biochemistry. 41:12100-12106.
2. Boix, E., D. D. Leonidas, ..., K. R. Acharya. 1999. Crystal structure of eosinophil cationic protein at 2.4 A. resolution. Biochemistry. 38:16794-16801.
3. Mallorquí-Fernández, G., J. Pous, ...,M. Coll. 2000. Three-dimensional crystal structure of human eosinophil cationic protein (RNase 3) at 1.75 A resolution. J. Mol. Biol. 300:1297-1307.
4. Laurents, D. V., M. Bruix, ..., M. Rico. 2009. The (1)H, (13)C, (15)N resonance assignment, solution structure, and residue level stability of eosinophil cationic protein/RNase 3 determined by NMR spectroscopy. Biopolymers. 91:1018-1028.
5. Santoro, J., C. González, ..., M. Rico. 1993. High-resolution threedimensional structure of ribonuclease A in solution by nuclear magnetic resonance spectroscopy. J. Mol, Biol. 229:722-734.
6. Monteseirin, J., A. Vega, ..., J. Conde. 2007. Neutrophils as a novel source of eosinophil cationic protein in IgE-mediated processes. J. Immunol. 179:2634-2641.
7. McLaren, D. J., C. G. Peterson, and P. Venge. 1984. Schistosoma mansoni: further studies of the interaction between schistosomula and granulocyte-derived cationic proteins in vitro. Parasitology. 88:491-503.
8. Hamann, K. J., G. J. Gleich, ..., R. L. Barker. 1990. In vitro killing of microfilariae of Brugia pahangi and Brugia malayi by eosinophil granule proteins. J. Immunol. 144:3166-3173.
9. Domachowske, J. B., K. D. Dyer, ..., H. F. Rosenberg. 1998. Eosinophil cationic protein/RNase 3 is another RNase A-family ribonuclease with direct antiviral activity. Nucleic Acids Res. 26:3358-3363.
10. Lehrer, R. I., D. Szklarek, ...,G. J. Gleich. 1989. Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein. J. Immunol. 142:4428-4434.
11. Boix, E., M. Torrent , ..., M. V. Nogués. 2008. The antipathogen activities of eosinophil cationic protein. Curr. Pharm. Biotechnol. 9:141-152.
12. Fredens, K., R. Dahl, and P. Venge. 1982. The Gordon phenomenon induced by the eosinophil cationic protein, and eosinophil protein X. J. Allergy Clin. Immunol, 70:361-366.
13. Young, J. D., C. G. Peterson, ...,Z. A. Conn. 1986. Mechanism of membrane damage mediated by human eosinophil cationic protein. Nature. 321:613-616.
14. Munthe-Kaas, M. C., J. Gerritsen, ...,K. L. Carlsen. 2007. Eosinophil cationic protein (ECP) polymorphisms and association with asthma, s-ECP levels and related phenotypes. Allergy. 62:429-436.
15. Woolcock, A. J., and J. K. Peat. 1.997. Evidence for the increase in asthma worldwide. Ciba Found. Symp. 206:122-134, discussion. 134 -129, 157-1129
16. Koh, G. C., L. P. Shek, ...,D. S. Koh. 2007. Eosinophil cationic protein: is it useful, in asthma? A systematic review. Respir. Med. 101:696-705.
17. Navarro, S., J. Aleu, ...,M. V. Nogués. 2008. The cytotoxicity of eosinophil cationic protein/ribonuclease 3 on eukaryotic cell lines takes place through its aggregation, on the cell membrane. Cell. Mol. Life Sci. 65:324-337.
18. Carreras, E., E. Boix, ...,M. V. Nogués. 2003. Both aromatic and cationic residues contribute to the memhrane-lytic and bactericidal activity of eosinophil cationic protein. Biochemistry. 42:6636-6644.
19. Sorrentino, S., and D. G. Glitz. 1991. Ribonuclease activity and substrate preference of human eosinophil cationic protein (ECP). FEBS Lett. 288:23-26.
20. Carreras, E., E. Boix, ..., M. V. Nogués. 2005. Surface-exposed amino acids of eosinophil cationic protein play a critical role in the inhibition of mammalian cell proliferation. Mol. Cell. Biochem. 272:1-7.
21. Trulson, A., J. Byström, ...,P. Venge. 2007. The functional heterogeneity of eosinophil cationic protein is determined by a gene polymorphism and post-translational modifications. Clin. Exp. Allergy. 37:208-218.
22. Fan, T. C., S. L. Fang, ...,M. D. Chang. 2008. Characterization of molecular interactions between eosinophil cationic protein and heparin. J. Biol. Chem. 283:25468-25474.
23. Cardin, A. D., and H. J. Weintraub. 1989. Molecular modeling of protein-glycosaminoglycan. interactions. Arteriosclerosis. 9:21-32.
24. Matsuzaki, K. 2009. Control of cell selectivity of antimicrobial peptides. Biochim, Biophys. Acta. 1788:1687-1692.
25. Verkleij, A. J., R. F. Zwaal, ...,L. L. van Deenen. 1973. The asymmetric distribution of phospholipids in the human red cell membrane. A combined study using phospholipases and freeze-etch electron microscopy. Biochim. Biophys. Acta. 323:178-193.
26. Murphy, J. W., Y. Cho, ..., E. Lolis. 2007. Structural and functional basis of CXCL12 (stromal cell-derived factor-1 alpha) binding to heparin. J. Biol. Chem. 282:10018-10027.
27. Sue, S. C., J. R. Brisson, ...,W. Wu. 2001, Structures of heparin-derived disaccharide bound to cobra cardiotoxins: context-dependent conformational change of heparin upon binding to the rigid core of the three-fingered toxin. Biochemistry. 40:10436-10446.
28. Maeda, T., K. Mahara, ...,H. Yamada. 2002. RNase 3 (ECP) is an extraordinarily stable protein among human pancreatic-type RNases. J. Biochem. 132:737-742.
29. Nikolovski, Z., V. Buzón, ...,M. V. Nogués. 2006. Thermal unfolding of eosinophil cationic protein/ribonuclease 3: a nonreversible process. Protein Sci. 15:2816-2827.
30. Klink, T. A., and R. T. Raines. 2000. Conformational stability is a determinant of ribonuclease A cytotoxicity. J. Biol. Chem. 275:17463-17467.
31. Nitto, T., K. D. Dyer, ...,H. F. Rosenberg. 2006. Evolution and function of leukocyte RNase A ribonucleases of the avian species, Gallus gallus. J. Biol. Chem. 281:25622-25634.
32. Torrent, M., B. G. de la Torre, ...,E. Boix. 2009. Bactericidal and membrane disruption activities of the eosinophil cationic protein are largely retained in an N-terminal fragment. Biochem. J. 421:425-434.
33. Boix, E., Z. Nikolovski, ...,M. V. Nogués. 1999. Kinetic and product distribution analysis of human eosinophil cationic protein indicates a subsite arrangement that favors exonuclease-type activity. J. Biol. Chem, 274:15605-15614.
34. Goddard, T. D., and D. G. Knell. 2005. Sparky 3. University of California, San Francisco, CA.
35. Koradi, R., M. Billeter, and K. Wüthrich. 1996. MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graph. 14:51-55, 29-32.
36. 1H-NMR studies on the conformational properties of peptide fragments from the C-terminal domain of thermolysin. Eur. J. Biochem. 211:569-581.
37. Wishart, D. S., B. D. Sykes, and F. M. Richards. 1991. Relationship between nuclear magnetic resonance chemical shift and protein secondary structure. J. Mol. Biol. 222:311-333.
38. Wüthrich, K. 1986. NMR. of Proteins and Nucleic Acids. Wiley-InterScience, John Wiley and Sons, New York, NY.
39. Luo, P., and R. L. Baldwin. 1997. Mechanism of helix induction by trifluoroethanol: a framework for extrapolating the helix-forming properties of peptides from trifluoroethanol/water mixtures back to water. Biochemistry. 36:8413-8421.
40. McDonnell, P. A., and S. J. Opella. 1993. Effect of detergent concentration on multidimensional solution NMR spectra of membrane proteins in micelles. J. Magn. Reson. 102:120-125.
41. Maeda, T., M. Kitazoe, ...,M. Seno. 2002. Growth, inhibition of mammalian cells by eosinophil cationic protein. Eur. J. Biochem. 269:307-316.
42. Mulloy, B., and E. A. Johnson. 1987. Assignment of the 1H-n.m.r. spectra of heparin and heparan, sulphate. Carbohydr. Res. 170:151-165.
43. Ramos, A., P. Bayer, and G. Varani. 1999-2000. Determination of the structure of the RNA complex of a double-stranded RNA-binding domain from. Drosophila Staufen protein. Biopolymers. 52:181-196.
44. Ramos, A., S. Grünert , ..., G. Varani. 2000. RNA recognition, by a Staufen double-stranded RNA-binding domain. EMBO J. 19:997-1009.
45. Torrent, M., M. V. Nogués, and E. Boix. Eosinophil cationic protein (ECP) can bind heparin and other glycosaminoglycans through, its RNase active site. J. Mol. Recognit. In press.
46. Rubin, J., U. Zagai, ...,P. Venge. 2009. The coding ECP 434(G>C) gene polymorphism determines the cytotoxicity of ECP but has minor effects on fibroblast-mediated gel contraction and no effect on RNase activity. J. Immunol. 183:445-451.
47. Gandhi, N. S., and R. L. Mancera. 2008. The structure of glycosaminoglycans and their interactions with proteins. Chem. Biol. Drug Des. 72:455-482.
48. Torrent, M., V. M. Nogués, and E. Boix. 2009. A theoretical approach to spot active regions in antimicrobial proteins. BMC Bioinformatics. 10:373.
49. Porcelli, F., R. Verardi, ...,G. Veglia. 2008. NMR structure of the cathelicidin-derived human antimicrobial peptide LL-37 in dodecylphosphocholine micelles. Biochemistry. 47:5565-5572.
50. Lequin, O., F. Bruston, ...,P. Nicolas. 2003. Helical structure of dermaseptin B2 in a membrane-mimetic environment. Biochemistry. 42:10311-10323.
51. Dubovskii, P. V., P. E. Volynsky, ...,A. S. Arseniev. 2006. Spatial structure and activity mechanism of a novel spider antimicrobial peptide. Biochemistry. 45:10759-10767.
52. Vogt, B., P. Ducarme, ...,B. Bechinger. 2000. The topology of lysinecontaining amphipathic peptides in bilayers by circular dichroism, solid-state NMR, and molecular modeling. Biophys. J. 79:2644-2656.
53. Woschnagg, C., J. Rubin, and P. Venge. 2009. Eosinophil cationic protein. (ECP) is processed during secretion. J. Immunol. 183: 3949-3954.
54. Ulrich, M., A. Petre, ...,G. Döring. 2008. Post-translational tyrosine nitration of eosinophil granule toxins mediated by eosinophil peroxidase. J. Biol. Chem. 283:28629-28640.
55. Iwasaki, W., K. Nagata, ...,F. Inagaki. 1997. Solution structure of midkine, a new heparin-binding growth factor. EMBO J. 16:6936-6946.
56. Spivak-Kroizman, T., M. A. Lemmon, ...,I. Lax. 1994. Heparininduced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation. Cell. 79: 1015-1024.
57. Fuchs, S. M., and R. T. Raines. 2006. Internalization of cationic peptides: The road less (or more?) traveled. Cell. Mol. Life Sci. 63:1819-1822.
58. Torrent, M., S. Navarro, ...,E. Boix. 2008. Eosinophil cationic protein high-affinity binding to bacteria-wall lipopolysaccharides and peptidoglycans. Biochemistry. 47:3544-3555.